Brief: Mira Pharmaceuticals Agrees To Acquire Skny Pharmaceuticals - SEC Filing
08/05/2025 12:51
May 8 (Reuters) - Mira Pharmaceuticals Inc MIRA.O: MIRA PHARMACEUTICALS INC - ON APRIL 30, AGREED TO ACQUIRE SKNY PHARMACEUTICALS - SEC FILING MIRA PHARMACEUTICALS INC - COMBINED ENTERPRISE VALUE EXCEEDS $60 MILLION - SEC FILING MIRA PHARMACEUTICALS INC -UNDER DEAL SKNY TO CONTRIBUTE $5 MILLION TO MIRA AT CLOSING - SEC FILING Source text: [ID:n0001641172-25-009155] Further company coverage: MIRA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mira Pharmaceuticals
See all newsBrief: Mira Pharmaceuticals - Alan Weichselbaum To Step Down As CFO Effective June 6, 2026 - SEC Filing
Brief: MIRA Pharmaceuticals Secures Worldwide Exclusive Rights To MIRA-55 And SKNY-1 - SEC Filing
Brief: Mira Pharmaceuticals Enters Into Amendment No 1 To Exclusive License Agreement With Miralogx
Brief: Mira Pharmaceuticals Inc - Completes Phase 1 Dosing Of Ketamir-2 - SEC Filing
Brief: Mira Pharmaceuticals Inc - Initiates Phase 1 Study Of Ketamir-2 - SEC Filing